tupungato
Tevogen Bio (NASDAQ:TVGN
) stock jumped nearly 30% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.
The Tevogen.AI initiative will
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1729779122/image_1729779122.jpg?io=getty-c-w750
2025-01-24 23:24:33
